{"id":"W4384463912","doi":"10.58931/cht.2022.1211","title":"Immunotherapy in Hodgkin lymphoma","year":2022,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Brentuximab vedotin; Medicine; Pembrolizumab; Nivolumab; Oncology; Internal medicine; Lymphoma; Clinical trial; Malignancy; Immunotherapy; Chemotherapy; Cancer; Hodgkin lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000572279,0.0002224318,0.0003708008,0.0005046115,0.0003625987,0.0005476145,0.0002637548,0.0009102967,0.003560296],"category_scores_gemma":[0.0005606312,0.000101951,0.000288993,0.000417173,0.0003843806,0.0004753386,0.0004307221,0.001329325,0.001059143],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001298581,"about_ca_system_score_gemma":0.001260909,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001772045,"about_ca_topic_score_gemma":0.003548789,"domain_scores_codex":[0.999788,0.00006962119,0.00001774366,0.00001901879,0.00005283047,0.00005284322],"domain_scores_gemma":[0.999806,0.00006855914,0.0000288409,0.00001069574,0.00003978121,0.00004611335],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003761641,0.0003803119,0.003308971,0.002200782,0.00006749212,0.001441325,0.0001632349,0.0008024838,0.006601662,0.01425698,0.08513162,0.8852691],"study_design_scores_gemma":[0.0003306484,0.0007597994,0.005585376,0.001355798,0.0000651371,0.005872759,0.0001099399,0.0003767494,0.002283381,0.008354331,0.9748872,0.00001898274],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01355475,0.9270723,0.00104142,0.0195792,0.003316354,0.0000758294,0.0001092488,0.00007461391,0.03517641],"genre_scores_gemma":[0.1393902,0.8137335,0.002432073,0.01926698,0.008283754,0.0001971953,0.0003789269,0.00002009107,0.01629729],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003560296,"threshold_uncertainty_score":0.01191038,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01106378067861947,"score_gpt":0.2438885588094986,"score_spread":0.2328247781308792,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}